Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bausch Health Companies Inc
(NY:
BHC
)
8.710
+0.090 (+1.04%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bausch Health Companies Inc
< Previous
1
2
3
4
5
Next >
Bausch Health to Announce First-Quarter 2023 Results on May 4
April 13, 2023
Via
ACCESSWIRE
New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider
April 04, 2023
Via
ACCESSWIRE
Bausch Health Announces Changes to its Board of Directors
March 01, 2023
Via
ACCESSWIRE
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
February 23, 2023
Via
ACCESSWIRE
Salix Announces 2023 Gastrointestinal Health Scholars Program
February 13, 2023
Via
ACCESSWIRE
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
February 01, 2023
Via
ACCESSWIRE
Bausch Health Announces Third-Quarter 2022 Results
November 03, 2022
Via
ACCESSWIRE
Ortho Dermatologics to Present New Data at the 2022 Innovations in Dermatology Conference
November 01, 2022
Via
ACCESSWIRE
Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge
October 31, 2022
Via
ACCESSWIRE
Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case
December 02, 2022
Via
ACCESSWIRE
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
December 01, 2022
Via
ACCESSWIRE
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
November 30, 2022
Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that.
Via
MarketBeat
Exposures
Product Safety
Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents
November 29, 2022
Via
ACCESSWIRE
Ortho Dermatologics To Present New Data at the 2022 Fall Clinical Dermatology Conference
October 20, 2022
Via
ACCESSWIRE
Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022
November 04, 2022
Via
ACCESSWIRE
Salix Will Present XIFAXAN(R) (Rifaximin), TRULANCE(R) (Plecanatide) and RELISTOR(R) (Methylnaltrexone Bromide) Data at The American College of Gastroenterology(R) 2022 Annual Scientific Meeting
October 24, 2022
Via
ACCESSWIRE
Bausch Health to Announce Third Quarter 2022 Results on Nov. 3
October 13, 2022
Via
ACCESSWIRE
Why These 3 Stocks Are Off to Hot September Starts
September 13, 2022
Let’s look at what is behind the surprise rise in these three names—and whether they can continue to pace this month’s market rally.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Bausch Health Companies Inc. (NYSE:BHC) Shareholder Notice: Investigation over Potential Wrongdoing
August 12, 2022
San Diego, CA -- (SBWIRE) -- 08/12/2022 -- An investigation as announced over potential breaches of fiduciary duties by certain directors at Bausch Health Companies Inc.
Via
SBWire
NYSE:BHC Investor Notice: Investigation over Possible Securities Laws Violations by Bausch Health Companies Inc.
May 18, 2022
San Diego, CA -- (SBWIRE) -- 05/18/2022 -- Bausch Health Companies Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
NYSE: BHC Shareholder Notice: Investigation over Potential Wrongdoing at Bausch Health Companies Inc.
September 13, 2021
San Diego, CA -- (SBWIRE) -- 09/13/2021 -- An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing at Bausch Health Companies Inc. was...
Via
SBWire
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Bausch Health Companies Inc. (NYSE:BHC) Investor Notice: Investigation over Possible Violations of Securities Laws
August 16, 2021
San Diego, CA -- (SBWIRE) -- 08/16/2021 -- Bausch Health Companies Inc is under investigation over potential securities laws in connection with certain financial statements.
Via
SBWire
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.